Ribomic Inc.
Notice Regarding the Suspension of Exercise for the 19th Stock Acquisition Rights (with Exercise Price Adjustment Clause) Issued Through a Third-Party Allotment
Notice of exercise blackout for the 19th stock acquisition rights to EVO FUND. The blackout period is 68 trading days from 2026/6/15 to 2026/9/18. Unexercised remaining units: 91,600 (shares: 9,160,000). Going forward, decisions to blackout or resume will be disclosed in a timely manner depending on market trends.
Key Figures
- 19th stock acquisition rights: 91,600 units
- Share equivalent: 9,160,000 shares
- Exercise blackout period: 2026/6/15〜2026/9/18
AI要約
Overview
Regarding the 19th issuance of stock acquisition rights issued through third-party allocation (exercise price revision clause attached), the company has decided on an exercise blackout and, based on a resale agreement with EVO FUND, has notified that the blackout period will be from June 15, 2026 to September 18, 2026. Unexercised remaining: 91,600 units (9,160,000 shares).
Future actions
After the effective date of the exercise blackout, the company may at any time permit the exercise of all or part of this stock acquisition right to the allottees, and will determine blackout or resume in light of stock price trends. Each time of resume or blackout, timely disclosure will be made through the Tokyo Stock Exchange.
Ribomic
Company overview · Stock price · Financial data · All IR
